You are here

FDA Urges Caution With Robotically Assisted Surgical Devices

Safety Risks for Patients Undergoing Mastectomies and Cancer Surgeries

The Food and Drug Administration (FDA) has warned against the use of robotically assisted devices for mastectomies and other cancer surgeries, stating that the products  may pose safety risks and result in poor outcomes for patients.

The agency said it decided to issue its warning after reviewing studies suggesting that robotically assisted devices were being used to perform cancer procedures for which there is limited data on their safety and effectiveness.

One recent study in the New England Journal of Medicine reported that use of the devices in radical hysterectomies in women with cervical cancer was associated with lower rates of disease-free survival and overall survival than traditional surgery.

The FDA also urges patients to discuss the risks, benefits, and alternative procedure options with their doctors before making treatment decisions, and to ask their doctors about their training, experience, and outcomes of patients they have treated with robotically assisted surgery.

Source: FDA, February 28, 2019

Recent Headlines

Scenesse is new treatment for people with rare, painful light sensitivity disease
Humira, Rituxan top list of drugs that added $5.1 billion to nation's health care bill
Lower court rulings cleared the way for generic versions of the MS drug
Maryland man wins lawsuit that alleges that the company's antipsychotic caused his gynecomastia
Antidepressants, ADHD meds are also used to self-poison
Study lists steps that could save close to $300 billion a year
While many victims used THC, the cause remains elusive
Descovy joins Truvada, another Gilead product, in the HIV prophylaxis market
Data show PTC Therapeutics drug preserves lung function